National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

sodium borocaptate
A boron-carrying compound. After parenteral administration, borocaptate sodium accumulates preferentially in tumor cells. When exposed to neutron irradiation, borocaptate absorbs neutrons and self-destructs releasing short-range alpha radiation and 'recoil' lithium in tumor cells, resulting in alpha radiation-induced tumor cell death. This highly selective, localized radiotargeting of tumor cells, known as boron neutron capture therapy (BNCT), spares adjacent normal tissues. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Foreign brand name:Borocarpin
Abbreviation:BSH



Previous:Slo-Phyllin, SMO inhibitor BMS 833923, SN-38-loaded polymeric micelles NK012, soblidotin, SOD1 inhibitor ATN-224
Next:sodium citrate, sodium dichloroacetate, sodium ferric gluconate complex in sucrose, sodium fluoride, sodium glycididazole

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov